Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Journal of Neurology, Neurosurgery, and Psychiatry|December 26, 2013
Predicting autoimmunity after alemtuzumab treatment of multiple sclerosisLaura Azzopardi, Sara A J Thompson, Katherine E Harding, et al.
Stem Cell Reports|February 13, 2026
The immunological profile of RC17 hESC-derived dopaminergic neural progenitor cells in vitro: Implications for the STEM-PD clinical trialAnnabel J Curle, Shaline V Fazal, Shamma Qarin, et al.
European Journal of Immunology|October 19, 2005
Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosisAmanda L Cox, Sara A J Thompson, Joanne L Jones, et al.
The Journal of Clinical Investigation|June 24, 2009
IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H)Joanne L Jones, Chia-Ling Phuah, Amanda L Cox, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 31, 2017
Extracellular Lactate: A Novel Measure of T Cell ProliferationJames T Grist, Lorna B Jarvis, Zoya Georgieva, et al.
Frontiers in Neurology|November 3, 2018
Monocyte Function in Parkinson's Disease and the Impact of Autologous Serum on PhagocytosisRuwani S Wijeyekoon, Deborah Kronenberg-Versteeg, Kirsten M Scott, et al.
Frontiers in Immunology|August 27, 2021
The MS Remyelinating Drug Bexarotene (an RXR Agonist) Promotes Induction of Human Tregs and Suppresses Th17 Differentiation In VitroChristopher M Gaunt, Daniel B Rainbow, Ruairi J Mackenzie, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 8, 2011
Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosisGrant A Hill-Cawthorne, Tom Button, Orla Tuohy, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2013
Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferationJoanne L Jones, Sara A J Thompson, Priscilla Loh, et al.
Genome Medicine|June 26, 2020
Discovery of CD80 and CD86 as recent activation markers on regulatory T cells by protein-RNA single-cell analysisDominik Trzupek, Melanie Dunstan, Antony J Cutler, et al.
Pageof 5